Literature DB >> 25146926

RIP kinases: key decision makers in cell death and innate immunity.

F Humphries1, S Yang1, B Wang1, P N Moynagh2.   

Abstract

Innate immunity represents the first line of defence against invading pathogens. It consists of an initial inflammatory response that recruits white blood cells to the site of infection in an effort to destroy and eliminate the pathogen. Some pathogens replicate within host cells, and cell death by apoptosis is an important effector mechanism to remove the replication niche for such microbes. However, some microbes have evolved evasive strategies to block apoptosis, and in these cases host cells may employ further countermeasures, including an inflammatory form of cell death know as necroptosis. This review aims to highlight the importance of the RIP kinase family in controlling these various defence strategies. RIP1 is initially discussed as a key component of death receptor signalling and in the context of dictating whether a cell triggers a pathway of pro-inflammatory gene expression or cell death by apoptosis. The molecular and functional interplay of RIP1 and RIP3 is described, especially with respect to mediating necroptosis and as key mediators of inflammation. The function of RIP2, with particular emphasis on its role in NOD signalling, is also explored. Special attention is given to emphasizing the physiological and pathophysiological contexts for these various functions of RIP kinases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25146926      PMCID: PMC4291486          DOI: 10.1038/cdd.2014.126

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  191 in total

Review 1.  True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.

Authors:  Edward S Mocarski; William J Kaiser; Devon Livingston-Rosanoff; Jason W Upton; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2014-03-01       Impact factor: 5.422

Review 2.  Recognition of cytosolic DNA by cGAS and other STING-dependent sensors.

Authors:  Numana Bhat; Katherine A Fitzgerald
Journal:  Eur J Immunol       Date:  2014-01-13       Impact factor: 5.532

Review 3.  The roles of Pellino E3 ubiquitin ligases in immunity.

Authors:  Paul N Moynagh
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

4.  Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration.

Authors:  Y Murakami; H Matsumoto; M Roh; A Giani; K Kataoka; Y Morizane; M Kayama; A Thanos; S Nakatake; S Notomi; T Hisatomi; Y Ikeda; T Ishibashi; K M Connor; J W Miller; D G Vavvas
Journal:  Cell Death Differ       Date:  2013-08-16       Impact factor: 15.828

5.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

Review 6.  More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling.

Authors:  Nufail Khan; Kate E Lawlor; James M Murphy; James E Vince
Journal:  Curr Opin Immunol       Date:  2013-11-30       Impact factor: 7.486

7.  cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner.

Authors:  W Wei-Lynn Wong; James E Vince; Najoua Lalaoui; Kate E Lawlor; Diep Chau; Aleksandra Bankovacki; Holly Anderton; Donald Metcalf; Lorraine O'Reilly; Philipp J Jost; James M Murphy; Warren S Alexander; Andreas Strasser; David L Vaux; John Silke
Journal:  Blood       Date:  2014-02-04       Impact factor: 22.113

8.  Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

Authors:  Huayi Wang; Liming Sun; Lijing Su; Josep Rizo; Lei Liu; Li-Feng Wang; Fu-Sheng Wang; Xiaodong Wang
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

9.  Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death.

Authors:  Xin Chen; Wenjuan Li; Junming Ren; Deli Huang; Wan-Ting He; Yunlong Song; Chao Yang; Wanyun Li; Xinru Zheng; Pengda Chen; Jiahuai Han
Journal:  Cell Res       Date:  2013-12-24       Impact factor: 25.617

10.  Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis.

Authors:  Q Remijsen; V Goossens; S Grootjans; C Van den Haute; N Vanlangenakker; Y Dondelinger; R Roelandt; I Bruggeman; A Goncalves; M J M Bertrand; V Baekelandt; N Takahashi; T V Berghe; P Vandenabeele
Journal:  Cell Death Dis       Date:  2014-01-16       Impact factor: 8.469

View more
  95 in total

1.  γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling.

Authors:  Jyoti Chhibber-Goel; Caroline Coleman-Vaughan; Vishal Agrawal; Neha Sawhney; Emer Hickey; James C Powell; Justin V McCarthy
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

2.  CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3.

Authors:  Jinho Seo; Eun-Woo Lee; Hyerim Sung; Daehyeon Seong; Yves Dondelinger; Jihye Shin; Manhyung Jeong; Hae-Kyung Lee; Jung-Hoon Kim; Su Yeon Han; Cheolju Lee; Je Kyung Seong; Peter Vandenabeele; Jaewhan Song
Journal:  Nat Cell Biol       Date:  2016-02-22       Impact factor: 28.824

Review 3.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

Review 4.  Exploiting host immunity: the Salmonella paradigm.

Authors:  Judith Behnsen; Araceli Perez-Lopez; Sean-Paul Nuccio; Manuela Raffatellu
Journal:  Trends Immunol       Date:  2015-01-09       Impact factor: 16.687

5.  Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells.

Authors:  Jaya Talreja; Harvinder Talwar; Nisar Ahmad; Ruchi Rastogi; Lobelia Samavati
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

6.  Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3)-Mixed Lineage Kinase Domain-Like Protein (MLKL)-Mediated Necroptosis Contributes to Ischemia-Reperfusion Injury of Steatotic Livers.

Authors:  Hong-Min Ni; Xiaojuan Chao; Joshua Kaseff; Fengyan Deng; Shaogui Wang; Ying-Hong Shi; Tiangang Li; Wen-Xing Ding; Hartmut Jaeschke
Journal:  Am J Pathol       Date:  2019-04-23       Impact factor: 4.307

7.  CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.

Authors:  Ting Zhang; Yan Zhang; Mingyao Cui; Li Jin; Yimei Wang; Fengxiang Lv; Yuli Liu; Wen Zheng; Haibao Shang; Jun Zhang; Mao Zhang; Hongkun Wu; Jiaojiao Guo; Xiuqin Zhang; Xinli Hu; Chun-Mei Cao; Rui-Ping Xiao
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

8.  Dynamin-Related Protein 1 Deficiency Leads to Receptor-Interacting Protein Kinase 3-Mediated Necroptotic Neurodegeneration.

Authors:  Tatsuya Yamada; Yoshihiro Adachi; Masahiro Fukaya; Miho Iijima; Hiromi Sesaki
Journal:  Am J Pathol       Date:  2016-09-15       Impact factor: 4.307

Review 9.  Targeting the NLRP3 inflammasome in inflammatory diseases.

Authors:  Matthew S J Mangan; Edward J Olhava; William R Roush; H Martin Seidel; Gary D Glick; Eicke Latz
Journal:  Nat Rev Drug Discov       Date:  2018-07-20       Impact factor: 84.694

10.  Catalytic in vivo protein knockdown by small-molecule PROTACs.

Authors:  Daniel P Bondeson; Alina Mares; Ian E D Smith; Eunhwa Ko; Sebastien Campos; Afjal H Miah; Katie E Mulholland; Natasha Routly; Dennis L Buckley; Jeffrey L Gustafson; Nico Zinn; Paola Grandi; Satoko Shimamura; Giovanna Bergamini; Maria Faelth-Savitski; Marcus Bantscheff; Carly Cox; Deborah A Gordon; Ryan R Willard; John J Flanagan; Linda N Casillas; Bartholomew J Votta; Willem den Besten; Kristoffer Famm; Laurens Kruidenier; Paul S Carter; John D Harling; Ian Churcher; Craig M Crews
Journal:  Nat Chem Biol       Date:  2015-06-10       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.